GCM
ELV icon

Gables Capital Management’s Elevance Health ELV Stock Holding History

Gables Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17
Closed -$4K – 360
2018
Q4 		$4K Hold
17
– – ﹤0.01% 316
2018
Q3 		$5K Hold
17
– – ﹤0.01% 321
2018
Q2 		$4K Buy
+17
New +$3.94K ﹤0.01% 336

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gables Capital Management's ELV Position: Q1 2019 in Review

Gables Capital Management sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 17 shares — an estimated $4K sold.

Gables Capital Management first reported a position in ELV in Q2 2018 and held it in 3 quarters. The position peaked at $5K in Q3 2018. 1,074 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • Gables Capital Management reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
  • Gables Capital Management sold 17 Elevance Health shares in Q1 2019, an estimated $4K.
  • Gables Capital Management first reported a position in Elevance Health in Q2 2018 and held it in 3 quarters.
  • Gables Capital Management's Elevance Health position peaked at $5K in Q3 2018.
  • 1,074 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Gables Capital Management's 13F filing for Q1 2019, filed 30 Apr 2019.